You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Boehringer Ingelheim

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-two approved drugs.

Summary for Actavis Mid Atlantic

Drugs and US Patents for Actavis Mid Atlantic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic DICLOFENAC SODIUM diclofenac sodium GEL;TOPICAL 206493-001 Dec 2, 2015 AB RX No No   Start Trial   Start Trial
Actavis Mid Atlantic METOCLOPRAMIDE HYDROCHLORIDE metoclopramide hydrochloride SOLUTION;ORAL 071340-001 Aug 18, 1988 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic NYSTATIN nystatin CREAM;TOPICAL 062949-001 Jun 13, 1988 AT RX No No   Start Trial   Start Trial
Actavis Mid Atlantic M-ZOLE 7 DUAL PACK miconazole nitrate CREAM, SUPPOSITORY;TOPICAL, VAGINAL 074586-001 Jul 17, 1997 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086578-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.